{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/diversity-action-plans-regulatory-requirements-and-clinical-trial-enrollment-goals#webpage",
"url": "https://www.fortrea.com/insights/diversity-action-plans-regulatory-requirements-and-clinical-trial-enrollment-goals",
"name": "Diversity Action Plans: regulatory requirements and clinical trial enrollment goals",
"description": "This Fortrea white paper explores the relationship between FDA regulatory requirements and clinical trial enrollment goals across clinical research programs. The content focuses on clinical trial enrollment goals, FDA expectations, patient recruitment planning, enrollment feasibility, protocol complexity, and operational approaches affecting study execution. The white paper highlights factors related to patient enrollment timelines, recruitment feasibility, protocol burden, site coordination, and FDA requirements influencing clinical trial performance and enrollment planning. Fortrea discusses operational and research perspectives designed to support enrollment strategy development, strengthen patient recruitment approaches, and improve coordination across clinical development activities. By integrating FDA regulatory expectations with enrollment planning and clinical trial execution strategies, the white paper provides insights into balancing regulatory requirements with clinical trial enrollment goals across evolving research programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Diversity Action Plans: regulatory requirements and clinical trial enrollment goals",
"item": "https://www.fortrea.com/insights/diversity-action-plans-regulatory-requirements-and-clinical-trial-enrollment-goals"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/diversity-action-plans-regulatory-requirements-and-clinical-trial-enrollment-goals#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/diversity-action-plans-regulatory-requirements-and-clinical-trial-enrollment-goals#webpage"
},
"headline": "Balancing Regulatory Requirements and Clinical Trial Enrollment Goals | Fortrea White Paper",
"description": "This Fortrea white paper explores the relationship between FDA regulatory requirements and clinical trial enrollment goals across clinical research programs. The content focuses on clinical trial enrollment goals, FDA expectations, patient recruitment planning, enrollment feasibility, protocol complexity, and operational approaches affecting study execution. The white paper highlights factors related to patient enrollment timelines, recruitment feasibility, protocol burden, site coordination, and FDA requirements influencing clinical trial performance and enrollment planning. Fortrea discusses operational and research perspectives designed to support enrollment strategy development, strengthen patient recruitment approaches, and improve coordination across clinical development activities. By integrating FDA regulatory expectations with enrollment planning and clinical trial execution strategies, the white paper provides insights into balancing regulatory requirements with clinical trial enrollment goals across evolving research programs.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-02/regulatory-requirements-and-clinical-trial-enrollment-goals.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-21",
"dateModified": "2025-02-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/regulatory-requirements-and-clinical-trial-enrollment-goals.pdf",
"encodingFormat": "application/pdf"
}
}
]
}